China and US based Harbour BioMed has announced a multi-year, global strategic collaboration and license agreement ...
US-based ALZpath, Inc., a leading developer of innovative diagnostic tools for Alzheimer's disease and related dementias...
Eli Lilly and Company has announced a plan to invest more than $6 billion in a new manufacturing facility in Huntsville,...
The US Food and Drug Administration (FDA) has approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spin...
American firms Abbott and Exact Sciences have announced a definitive agreement for Abbott to acquire Exact Sciences, whi...
Global biopharma leader CSL has announced plans to expand its US presence over the next five years, resulting in approxi...
Thermo Fisher Scientific Inc. has announced the grand opening of its East Coast flagship Advanced Therapies Collaboratio...
Puerto Rico’s transformation into a powerhouse of advanced biopharmaceutical manufacturing is gaining new momentum...
Waters Corporation has announced the launch of its Charged Aerosol Detector (CAD) specifically designed for use with Wat...
Thermo Fisher Scientific Inc., the world leader in serving science, has announced a definitive agreement to acquire Clar...
The project will modernize Lilly’s facilities in Carolina, generate over 1,100 new jobs across construction and op...
MilliporeSigma, the US and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technol...
US-based Waters Corporation has unveiled the Waters Xevo Charge Detection Mass Spectrometer (CDMS), delivering...
AstraZeneca will invest $4.5 billion in its new manufacturing facility in Virginia, US, a proposed increase of $500 mill...
Global pharmaceutical leader Lupin has announced its plans for a new state-of-the-art pharmaceutical manufacturing plant...
Japanese pharmaceutical firm Daiichi Sankyo has established Daiichi Sankyo Research Institute in San Diego, US represent...
The PPD™ clinical research business of Thermo Fisher Scientific, has announced a new research and development (R&a...
AbbVie has announced the start of construction of a $70 million expansion at its AbbVie Bioresearch Center (ABC) in...
